GSK Statistics

Total Valuation

GSK has a market cap or net worth of $109.34 billion. The enterprise value is $128.18 billion.

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026, before market open.

Share Statistics

GSK has 4.01 billion shares outstanding. The number of shares has decreased by -0.60% in one year.

Valuation Ratios

The trailing PE ratio is 14.21 and the forward PE ratio is 11.03.

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.40, with an EV/FCF ratio of 14.83.

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.

Financial Efficiency

Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.53%.

Taxes

In the past 12 months, GSK has paid $1.50 billion in taxes.

Stock Price Statistics

The stock price has increased by +45.53% in the last 52 weeks. The beta is 0.35, so GSK's price volatility has been lower than the market average.

Short Selling Information

The latest short interest is 15.45 million, so 0.77% of the outstanding shares have been sold short.

Income Statement

In the last 12 months, GSK had revenue of $43.97 billion and earned $7.69 billion in profits. Earnings per share was $1.87.

Balance Sheet

The company has $4.60 billion in cash and $23.94 billion in debt, giving a net cash position of -$19.34 billion or -$4.82 per share.

Cash Flow

In the last 12 months, operating cash flow was $10.42 billion and capital expenditures -$1.81 billion, giving a free cash flow of $8.64 billion.

Margins

Gross margin is 72.61%, with operating and profit margins of 28.92% and 17.50%.

Dividends & Yields

This stock pays an annual dividend of $1.75, which amounts to a dividend yield of 3.20%.

Analyst Forecast

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 1:1.25.

Scores

GSK has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.